Back to Search Start Over

Further delineation of dosage-sensitive K/L mediated Xq28 duplication syndrome includes incomplete penetrance.

Authors :
Leffler M
Christie L
Hackett A
Bennetts B
Goel H
Amor DJ
Peters GB
Field M
Dudding-Byth T
Source :
Clinical genetics [Clin Genet] 2023 Jun; Vol. 103 (6), pp. 681-687. Date of Electronic Publication: 2023 Feb 16.
Publication Year :
2023

Abstract

The low copy tandem repeat area at Xq28 is prone to recurrent copy number gains, including the K/L mediated duplications of 300 kb size (herein described as the K/L mediated Xq28 duplication syndrome). We describe five families, including nine males with K/L mediated Xq28 duplications, some with regions of greater copy number variation (CNV). We summarise findings in 25 affected males reported to date. Within the five families, males were variably affected by seizures, intellectual disability, and neurological features; however, one male with a familial K/L mediated Xq28 duplication has normal intelligence, suggesting that this CNV is not 100% penetrant. Including our five families, 13 carrier females have been identified, with nine presenting phenotypically normal. Three carrier females reported mild learning difficulties, and all of them had duplications containing regions with at least four copies. Delineation of the spectrum of K/L mediated Xq28 duplication syndrome highlights GDI1 as the most likely candidate gene contributing to the phenotype. For patients identified with CNVs in this region, high-resolution microarray is required to define copy number gains and provide families with accurate information.<br /> (© 2023 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1399-0004
Volume :
103
Issue :
6
Database :
MEDLINE
Journal :
Clinical genetics
Publication Type :
Academic Journal
Accession number :
36688272
Full Text :
https://doi.org/10.1111/cge.14303